Stockreport

UBS Shrugs Abbott Laboratories' (ABT) Diagnostic Weakness Affirms ‘Buy' Rating [Yahoo! Finance]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF Abbott Laboratories (NYSE: ABT ) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty . On July 21, UBS reiterated a ‘Buy' rating [Read more]